{"id":6540,"date":"2020-11-20T10:35:16","date_gmt":"2020-11-20T09:35:16","guid":{"rendered":"https:\/\/forum.schreiner-group.com\/?p=6540"},"modified":"2020-11-20T10:35:16","modified_gmt":"2020-11-20T09:35:16","slug":"customized-labels-support-covid-19-vaccine-candidates","status":"publish","type":"post","link":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/","title":{"rendered":"Customized Labels Support Covid-19 Vaccine Candidates"},"content":{"rendered":"<section class=\"wpb-content-wrapper\"><p>[vc_row full_width=&#8221;stretch_row_content_no_spaces&#8221; content_placement=&#8221;top&#8221; css=&#8221;.vc_custom_1605775302381{margin-top: 150px !important;}&#8221; parallax_background_image=&#8221;6929&#8243;][vc_column][vc_empty_space height=&#8221;615px&#8221;][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1594636600423{background-color: #ffffff !important;}&#8221; el_class=&#8221;article_bighead&#8221;][vc_column][vc_custom_heading text=&#8221;SCHREINER MEDIPHARM&#8221; font_container=&#8221;tag:h2|text_align:center&#8221; use_theme_fonts=&#8221;yes&#8221; el_class=&#8221;topcategory&#8221;][vc_custom_heading text=&#8221;Customized Labels Support Covid-19 Vaccine Candidates&#8221; font_container=&#8221;tag:h1|text_align:center&#8221; use_theme_fonts=&#8221;yes&#8221;][vc_column_text]<strong>In the fall of 2020, pharmaceutical corporations around the world were engaged in more than 180 research projects for a vaccine against the corona virus. However, it normally takes several years for a vaccine to reach market readiness. In the case of the new SARS-CoV-2 pathogen, pharmaceutical corporations and research institutes have responded faster than ever in order to accelerate time-to-market. Marking specialists like Schreiner MediPharm with long-standing experience in the area of vaccines and a portfolio of appropriate packaging and label solutions are able to provide vaccine developers with efficient and reliable support\u2014from clinical trials to market launch and high-volume production.<\/strong>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_row_inner css=&#8221;.vc_custom_1594202372538{padding-top: 3% !important;padding-bottom: 3% !important;}&#8221;][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text]<strong>Clinical Research<\/strong><br \/>\nClinical trials require label solutions that optimize processes, provide product information in several languages and blind the investigational products. A team of experts specialized in Clinical Trial Supplies (CTS) at Schreiner Medi-<br \/>\nPharm provides consulting support to customers across all stages of a study. Subsequently, a customized labeling solution is developed for fast and flexible use according to the specific requirement. A Booklet-Label with many pages<br \/>\nfor international trials or a semi-transparent, colored label for blinding investigational products in transparent containers are two examples of such solutions.[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][vc_column_text]<strong>Market Launch and High-Volume Production<\/strong><br \/>\nAs soon as a vaccine is ready for the market, it requires a marking label. The vaccine label must be available in a form that guarantees reliable processing to ensure that the high demand for vaccine doses can be met quickly across the<br \/>\nboard. Application-specific adaptation of the label\u2014be it for unit-dose or multi-dose vials or for prefilled syringes\u2014is a decisive factor in this context. Additional functions can facilitate subsequent handling and enhance patient safety. These can be detachable label parts for documentation in vaccination records or for marking containers after refilling processes as well as integrated overt or covert security features for product authentication.[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][vc_column_text]How fast a mass immunization campaign can be rolled out not least depends on available production capacities. Efficient workflow and qualified materials in label manufacturing processes ensure supply chain reliability and provide pharmaceutical manufacturers with absolute planning certainty. A supply partner with adequate production capacities that can be ramped up as needed, as well as the ability to produce on an identically high level of quality at several sites, is an important resource in this context. It enables flexible response to adjustments of required quantities and demand, and thus supports the security of vaccine supply.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;][vc_empty_space height=&#8221;50px&#8221;][vc_single_image image=&#8221;6534&#8243; img_size=&#8221;large&#8221; add_caption=&#8221;yes&#8221;][vc_empty_space height=&#8221;25px&#8221;][vc_single_image image=&#8221;6959&#8243; img_size=&#8221;large&#8221; add_caption=&#8221;yes&#8221;][vc_empty_space height=&#8221;25px&#8221;][vc_single_image image=&#8221;6538&#8243; img_size=&#8221;large&#8221; add_caption=&#8221;yes&#8221;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=&#8221;Efficient and reliable\u2013<br \/>\nfrom vaccine development to production&#8221; font_container=&#8221;tag:h2|text_align:left|color:%237ea0d4&#8243; google_fonts=&#8221;font_family:Lato%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C700%2C700italic%2C900%2C900italic|font_style:400%20regular%3A400%3Anormal&#8221;][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>In the fall of 2020, pharmaceutical corporations around the world were engaged in more than 180 research projects for a vaccine against the corona virus. However, it normally takes several years for a vaccine to reach market readiness. In the case of the new SARS-CoV-2 pathogen, pharmaceutical corporations and research institutes have responded faster than ever in order to accelerate time-to-market. Marking specialists like Schreiner MediPharm with long-standing experience in the area of vaccines and a portfolio of appropriate packaging and label solutions are able to provide vaccine developers with efficient and reliable support\u2014from clinical trials to market launch and high-volume production.<\/p>\n","protected":false},"author":2,"featured_media":7028,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[187],"tags":[200],"class_list":["post-6540","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-schreiner-medipharm-en","tag-marking-solutions"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Customized Labels Support Covid-19 Vaccine Candidates - Schreiner Group Forum<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Customized Labels Support Covid-19 Vaccine Candidates - Schreiner Group Forum\" \/>\n<meta property=\"og:description\" content=\"In the fall of 2020, pharmaceutical corporations around the world were engaged in more than 180 research projects for a vaccine against the corona virus. However, it normally takes several years for a vaccine to reach market readiness. In the case of the new SARS-CoV-2 pathogen, pharmaceutical corporations and research institutes have responded faster than ever in order to accelerate time-to-market. Marking specialists like Schreiner MediPharm with long-standing experience in the area of vaccines and a portfolio of appropriate packaging and label solutions are able to provide vaccine developers with efficient and reliable support\u2014from clinical trials to market launch and high-volume production.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/\" \/>\n<meta property=\"og:site_name\" content=\"Schreiner Group Forum\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-20T09:35:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2020\/11\/SMP_Label_Impfstoff_Preview.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"markus.liedl@schreiner-group.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"markus.liedl@schreiner-group.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/\",\"url\":\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/\",\"name\":\"Customized Labels Support Covid-19 Vaccine Candidates - Schreiner Group Forum\",\"isPartOf\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2020\/11\/SMP_Label_Impfstoff_Preview.jpg\",\"datePublished\":\"2020-11-20T09:35:16+00:00\",\"dateModified\":\"2020-11-20T09:35:16+00:00\",\"author\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc\"},\"breadcrumb\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#primaryimage\",\"url\":\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2020\/11\/SMP_Label_Impfstoff_Preview.jpg\",\"contentUrl\":\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2020\/11\/SMP_Label_Impfstoff_Preview.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/forum.schreiner-group.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Customized Labels Support Covid-19 Vaccine Candidates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#website\",\"url\":\"https:\/\/forum.schreiner-group.com\/de\/\",\"name\":\"Schreiner Group Forum\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/forum.schreiner-group.com\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc\",\"name\":\"markus.liedl@schreiner-group.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g\",\"caption\":\"markus.liedl@schreiner-group.com\"},\"url\":\"https:\/\/forum.schreiner-group.com\/en\/author\/markus-liedlschreiner-group-de\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Customized Labels Support Covid-19 Vaccine Candidates - Schreiner Group Forum","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/","og_locale":"en_US","og_type":"article","og_title":"Customized Labels Support Covid-19 Vaccine Candidates - Schreiner Group Forum","og_description":"In the fall of 2020, pharmaceutical corporations around the world were engaged in more than 180 research projects for a vaccine against the corona virus. However, it normally takes several years for a vaccine to reach market readiness. In the case of the new SARS-CoV-2 pathogen, pharmaceutical corporations and research institutes have responded faster than ever in order to accelerate time-to-market. Marking specialists like Schreiner MediPharm with long-standing experience in the area of vaccines and a portfolio of appropriate packaging and label solutions are able to provide vaccine developers with efficient and reliable support\u2014from clinical trials to market launch and high-volume production.","og_url":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/","og_site_name":"Schreiner Group Forum","article_published_time":"2020-11-20T09:35:16+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2020\/11\/SMP_Label_Impfstoff_Preview.jpg","type":"image\/jpeg"}],"author":"markus.liedl@schreiner-group.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"markus.liedl@schreiner-group.com","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/","url":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/","name":"Customized Labels Support Covid-19 Vaccine Candidates - Schreiner Group Forum","isPartOf":{"@id":"https:\/\/forum.schreiner-group.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#primaryimage"},"image":{"@id":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#primaryimage"},"thumbnailUrl":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2020\/11\/SMP_Label_Impfstoff_Preview.jpg","datePublished":"2020-11-20T09:35:16+00:00","dateModified":"2020-11-20T09:35:16+00:00","author":{"@id":"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc"},"breadcrumb":{"@id":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#primaryimage","url":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2020\/11\/SMP_Label_Impfstoff_Preview.jpg","contentUrl":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2020\/11\/SMP_Label_Impfstoff_Preview.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/forum.schreiner-group.com\/en\/customized-labels-support-covid-19-vaccine-candidates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/forum.schreiner-group.com\/en\/"},{"@type":"ListItem","position":2,"name":"Customized Labels Support Covid-19 Vaccine Candidates"}]},{"@type":"WebSite","@id":"https:\/\/forum.schreiner-group.com\/de\/#website","url":"https:\/\/forum.schreiner-group.com\/de\/","name":"Schreiner Group Forum","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/forum.schreiner-group.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc","name":"markus.liedl@schreiner-group.com","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g","caption":"markus.liedl@schreiner-group.com"},"url":"https:\/\/forum.schreiner-group.com\/en\/author\/markus-liedlschreiner-group-de\/"}]}},"_links":{"self":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts\/6540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/comments?post=6540"}],"version-history":[{"count":5,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts\/6540\/revisions"}],"predecessor-version":[{"id":6961,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts\/6540\/revisions\/6961"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/media\/7028"}],"wp:attachment":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/media?parent=6540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/categories?post=6540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/tags?post=6540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}